Biotech · Private company · East Hanover, NJ, US

Myracle Therapeutics Inc

Track this companyFree. Adds Myracle Therapeutics Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards1

Discovery and optimization of novel, selective HDAC11 inhibitors for the treatment of obesity and related diseases.Fiscal year 2024 · $324.5KNIH RePORTER 1R44DK139886-01 · fetched Nov 12, 2026